Cargando…

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

BACKGROUND: Coronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Wei, Fan, Zheng, Chu, Yanqi, Wang, Haizheng, Yang, Ying, Wu, Li, Sun, Nan, Sun, Ge, Shen, Yuqiao, Lin, Xiaolan, Guo, Guiming, Xi, Shengyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396557/ https://www.ncbi.nlm.nih.gov/pubmed/32848729 http://dx.doi.org/10.3389/fphar.2020.01066

Ejemplares similares

Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update
por: Zhuang, Wei, et al.
Publicado: (2021)

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Zhang, Nan, et al.
Publicado: (2020)

Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Frontiers Production Office,
Publicado: (2021)

Role of Traditional Chinese Medicine in the Management of Viral Pneumonia
por: Xi, Shengyan, et al.
Publicado: (2020)

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
por: Qiu, Qin, et al.
Publicado: (2020)

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
por: Wu, Ying, et al.
Publicado: (2021)

Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019
por: Liu, Jingyuan, et al.
Publicado: (2021)

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
por: Duan, Nai-fan, et al.
Publicado: (2021)

Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
por: Wang, Heping, et al.
Publicado: (2021)

Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Lihui, et al.
Publicado: (2023)

Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease Complicated With Osteoporosis
por: Xu, Weifan, et al.
Publicado: (2022)

TaqMan Probe-Based Quantitative Real-Time PCR to Detect Panax notoginseng in Traditional Chinese Patent Medicines
por: Lou, Qian, et al.
Publicado: (2022)

Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis
por: Jiang, Li, et al.
Publicado: (2022)

The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials
por: Huang, Peiying, et al.
Publicado: (2022)

An Efficacy and Feasibility Analysis of Chinese Patent Medicine Combined With Letrozole in the Treatment of Women With Ovulation Disorders: A Network Meta-Analysis
por: Zhu, Jing-Yan, et al.
Publicado: (2021)

Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines
por: Liu, Suyan, et al.
Publicado: (2021)

Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China
por: Wu, Jieya, et al.
Publicado: (2021)

Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Yang, et al.
Publicado: (2021)

Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Min, et al.
Publicado: (2018)

Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019
por: Chen, Bowu, et al.
Publicado: (2023)

Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019
por: Zhang, Jiaxing, et al.
Publicado: (2020)

Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis
por: Xie, Yufei, et al.
Publicado: (2022)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats
por: Luo, Jiaoyang, et al.
Publicado: (2017)

Observation of Voriconazole in the Treatment of Liver Failure Complicated With Invasive Pulmonary Fungal Infection Induced by Chinese Patent Medicine in Teenagers: 2 Case Reports
por: Su, Qian, et al.
Publicado: (2022)

Comparative clinical-related outcomes of Chinese patent medicines for cardiac hypertrophy: A systematic review and network meta-analysis of randomized clinical trials
por: Zhang, Tianqi, et al.
Publicado: (2023)

Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis
por: Bi, Yufei, et al.
Publicado: (2023)

A specific SNP-based multiplex PCR assay for the simultaneous identification of two biological ingredients for the Chinese patent medicine, Danggui Buxue pill
por: Liu, Yinrong, et al.
Publicado: (2023)

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
por: Vandenplas, Yannick, et al.
Publicado: (2021)

Partial response to Chinese patent medicine Kangliu pill for adult glioblastoma: A case report and review of the literature
por: Sun, Ge, et al.
Publicado: (2021)

Interaction between Chinese medicine and digoxin: Clinical and research update
por: Zhuang, Wei, et al.
Publicado: (2023)

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
por: Zhu, Wei, et al.
Publicado: (2019)

Assesment of Adulterated Traditional Chinese Medicines in China: 2003-2017
por: Xu, Mingzhe, et al.
Publicado: (2019)

The Species Identification in Traditional Herbal Patent Medicine, Wuhu San, Based on Shotgun Metabarcoding
por: Liu, Jinxin, et al.
Publicado: (2021)

Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine
por: Luo, Chuan-hong, et al.
Publicado: (2020)

Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis
por: Liu, Jiarong, et al.
Publicado: (2022)

Biofunctional roles of estrogen in coronavirus disease 2019: Beyond a steroid hormone
por: Wang, Zhong-Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3qpdb2b1s94dg9nd5c0424mhc